MedTrace Logo

Randomized Controlled Trial of Early Palliative Care for Patients With Advanced Cancer

NCT01248624 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 461

Last updated 2025-06-26

No results posted yet for this study

Summary

Patients with advanced cancer often have numerous physical and psychological symptoms, which can negatively affect their quality of life. A palliative care team of different health care professionals (including doctors, nurses, social workers and therapists) specializes in treating these symptoms and offers support for patients and their families. However, palliative care teams are currently involved only in the last two months of a patient's life or not at all.

The main purpose of this study is to determine whether, compared to conventional cancer care, early involvement by a specialized symptom control and palliative care team in patients with advanced cancer will be associated with: better quality of life, greater patient and caregiver satisfaction with care, better symptom control, improved communication with healthcare providers and improved caregiver quality of life.

Conditions

Interventions

BEHAVIORAL

Early Palliative Care Referral

The intervention arm receives early referral to and follow-up by a symptom control and palliative care team at Princess Margaret Hospital.

Sponsors & Collaborators

  • Canadian Cancer Society (CCS)

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Camilla Zimmermann, MD, PhD · Princess Margaret Cancer Centre, University Health Network

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2011-06-30
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01248624 on ClinicalTrials.gov